Larotracking: Real-life study of locally advanced/metastatic solid tumor treated with larotrectinib in French expanded access program

被引：0
|
作者：
Dufresne, A. [1 ]
Huillard, O. [2 ]
Dalban, C. [3 ]
Geier, M. [4 ]
Wassermann, J. [5 ,6 ]
Zanetta, S. [7 ]
Cabourg, M. [8 ]
Catargi, B. [9 ]
El Kouri, C. [10 ]
Hrab, I. [11 ]
Laramas, M. [12 ]
Moreira, A. [13 ]
Saada, E. B. [14 ]
Tournigand, C. [15 ]
Valentin, T. [16 ]
Vauleon, E. [17 ]
Mayet, R.
Perol, D. [18 ]
Blay, J-Y. [19 ]
机构：
[1] Ctr Leon Berard, Med Oncol, Lyon, France
[2] Hop Cochin, AP HP, Med Oncol, Paris, France
[3] Ctr Leon Berard, Clin Res Dept, Lyon, France
[4] Univ Hosp Brest, CHRU Morvan, Med Oncol, Brest, France
[5] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Thyroid & Endocrine Tumors,GRC Tumeurs Thyro, Paris, France
[6] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Med Oncol Dept,GRC Tumeurs Thyroidienned,IUC,GRC, Paris, France
[7] Ctr Georges Francois Leclerc, Med Oncol, Dijon, France
[8] Hosp Ctr Intercommunal Elbeuf Louviers Val De Reu, Med Oncol, St Aubin, France
[9] Hop St Andre, CHU Bordeaux, Endocrinol, Bordeaux, France
[10] Ctr Catherine Sienne, Med Oncol, Nantes, France
[11] Ctr Francois Baclesse, Med Oncol, Caen, France
[12] CHU Grenoble Alpes Site Nord, Med Oncol, La Tronche, France
[13] CHU Amiens, Med Oncol, Amiens, France
[14] Ctr Antoine Lacassagne, Med Oncol, Nice, France
[15] Ctr Hosp Univ Henri Mondor, AP HP, Med Oncol, Creteil, France
[16] Inst Univ Canc Toulouse Oncopole, Med Oncol, Toulouse, France
[17] Ctr Eugene Marquis, Med Oncol, Rennes, France
[18] Ctr Leon Berard, Clin Res Dept, Lyon, France
[19] Ctr Leon Berard, Med Dept, Lyon, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.594
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
465P
引用
收藏
页码：S753 / S753
页数：1
相关论文
共 50 条
  • [21] Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
    Heery, Christopher R.
    O'Sullivan-Coyne, Geraldine
    Madan, Ravi A.
    Cordes, Lisa
    Rajan, Arun
    Rauckhorst, Myrna
    Lamping, Elizabeth
    Oyelakin, Israel
    Marte, Jennifer L.
    Lepone, Lauren M.
    Donahue, Renee N.
    Grenga, Italia
    Cuillerot, Jean-Marie
    Neuteboom, Berend
    von Heydebreck, Anja
    Chin, Kevin
    Schlom, Jeffrey
    Gulley, James L.
    LANCET ONCOLOGY, 2017, 18 (05): : 587 - 598
  • [22] Nationwide Real-Life Safety and Treatment Exposure Data on Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III, Locally Advanced, Non-small Cell Lung Cancer: Analysis of Patients Enrolled in the French Early Access Program
    Avrillon, Virginie
    Daniel, Catherine
    Boisselier, Pierre
    Le Pechoux, Cecile
    Chouaid, Christos
    LUNG, 2022, 200 (01) : 95 - 105
  • [23] Nationwide Real-Life Safety and Treatment Exposure Data on Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III, Locally Advanced, Non-small Cell Lung Cancer: Analysis of Patients Enrolled in the French Early Access Program
    Virginie Avrillon
    Catherine Daniel
    Pierre Boisselier
    Cécile Le Péchoux
    Christos Chouaid
    Lung, 2022, 200 : 95 - 105
  • [24] An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
    Capri, G.
    Chang, J.
    Chen, S. -C.
    Conte, P.
    Cwiertka, K.
    Jerusalem, G.
    Jiang, Z.
    Johnston, S.
    Kaufman, B.
    Link, J.
    Ro, J.
    Schuette, J.
    Oliva, C.
    Parikh, R.
    Preston, A.
    Rosenlund, J.
    Selzer, M.
    Zembryki, D.
    De Placido, S.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 474 - 480
  • [25] Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience
    Lamy, Tina
    Cabarrou, Bastien
    Planchard, David
    Quantin, Xavier
    Schneider, Sophie
    Bringuier, Michael
    Besse, Benjamin
    Girard, Nicolas
    Chouaid, Christos
    Filleron, Thomas
    Simon, Gaetane
    Baldini, Capucine
    CANCERS, 2022, 14 (01)
  • [26] Spanish Multicenter Retrospective Study of Real-Life Experience of Advanced NSCLC with EGFR Exon 20 Insertions Treated With Amivantamab
    Albarran-Artahona, V.
    Torres-Jimenez, J.
    Auclin, E.
    Esteban-Villarrubia, J.
    Sanchez-Gastaldo, A.
    Benitez-Lopez, G.
    Garde-Noguera, J.
    Perez-Gracia, J. L.
    Soler, J.
    Areses, M.
    Olmedo-Garcia, E.
    Insa, A.
    Torres-Martinez, A.
    Roa, D.
    Dorta, M.
    Cardenas, N.
    Laguna, J. C.
    Teixido, C.
    Mezquita, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S474 - S475
  • [27] Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
    Toulmonde, Maud
    Dinart, Derek
    Brahmi, Mehdi
    Verret, Benjamin
    Jean-Denis, Myriam
    Ducimetiere, Francoise
    Desolneux, Gregoire
    Meeus, Pierre
    Palussiere, Jean
    Buy, Xavier
    Bouhamama, Amine
    Gillon, Pauline
    Dufresne, Armelle
    Henon, Clemence
    Le Loarer, Francois
    Karanian, Marie
    Ngo, Carine
    Mathoulin-Pelissier, Simone
    Bellera, Carine
    Le Cesne, Axel
    Blay, Jean Yves
    Italiano, Antoine
    CANCERS, 2023, 15 (17)
  • [28] IFCT-1502 CLINIVO: Real-life experience with nivolumab in 600 patients (pts) with advanced non-small cell lung cancer (NSCLC): Efficacy and safety of nivolumab and post-nivolumab treatment in the French Expanded Access Program (EAP)
    Girard, N.
    Valette, C. Audigier
    Cadranel, J.
    Monnet, I.
    Hureaux, J.
    Hilgers, W.
    Fauchon, E.
    Fabre, E.
    Besse, B.
    Brun, P.
    Coetmeur, D.
    Quoix, E.
    Mourlanette, P.
    Barlesi, F.
    Bordenave-Caffre, S.
    Egenod, T.
    Missy, P.
    Morin, F.
    Moro-Sibilot, D.
    Molinier, O.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
    Strippoli, Sabino
    Fanizzi, Annarita
    Quaresmini, Davide
    Nardone, Annalisa
    Armenio, Andrea
    Figliuolo, Francesco
    Filotico, Raffaele
    Fucci, Livia
    Mele, Fabio
    Traversa, Michele
    De Luca, Federica
    Montagna, Elisabetta Sara
    Ruggieri, Eustachio
    Ferraiuolo, Simona
    Macina, Francesco
    Tommasi, Stefania
    Sciacovelli, Angela Monica
    De Risi, Ivana
    Albano, Anna
    Massafra, Raffaella
    Guida, Michele
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study
    Tuninetti, Valentina
    Virano, Elisa
    Salutari, Vanda
    Ricotti, Andrea
    Pisano, Carmela
    Ducceschi, Monika
    Turitto, Giacinto
    Scandurra, Giuseppa
    Petrella, Maria Cristina
    Forestieri, Valeria
    Rizzetto, Monica
    Mammoliti, Serafina
    Artioli, Grazia
    Cioffi, Raffaella
    Borsotti, Lucia
    Bellero, Marco
    Rognone, Chiara
    Carbone, Vittoria
    Ferrandina, Gabriella
    Mantiero, Mara
    Azzolina, Carmen
    Geninatti, Eleonora
    Pignata, Sandro
    Valabrega, Giorgio
    EUROPEAN JOURNAL OF CANCER, 2024, 203
12345